Cidara Therapeutics, Inc. (CDTX)
219.97
-0.10
(-0.05%)
USD |
NASDAQ |
Dec 09, 14:56
Cidara Therapeutics Shareholders Equity (Quarterly): 422.39M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 51.85B |
| Bristol Myers Squibb Co. | 18.55B |
| Johnson & Johnson | 79.28B |
| Mersana Therapeutics, Inc. | -59.54M |
| Pfizer Inc. | 92.80B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 518.65M |
| Total Liabilities (Quarterly) | 96.26M |
| Debt to Equity Ratio | 0.0047 |
| Current Ratio | 4.620 |
| Net Debt Paydown Yield | 0.02% |